Stryker Corporation
SYK
Classement en actions
#190
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Prix de l'action
$304.72
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$116.88B
Changement (1 jour)
1.96%
Changement (1 an)
-19.76%
Pays
US
Échange Stryker Corporation (SYK)
Catégorie
Healthcare
Ratio P/E pour Stryker Corporation (SYK)
Ratio P/E au October 2026 TTM : 28.94
Selon les derniers rapports financiers et le cours de l'action de Stryker Corporation, le ratio P/E actuel (TTM) est de 28.94. À la fin de l’année 2024, le P/E de l’entreprise était de 45.83.
Historique du ratio P/E pour Stryker Corporation de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 28.94 | -30.05% |
| 2025 | 41.38 | -9.71% |
| 2024 | 45.83 | 27.61% |
| 2023 | 35.92 | -8.41% |
| 2022 | 39.21 | -22.44% |
| 2021 | 50.56 | -12.14% |
| 2020 | 57.54 | 52.66% |
| 2019 | 37.69 | 128.39% |
| 2018 | 16.50 | -70.93% |
| 2017 | 56.77 | 108.63% |
| 2016 | 27.21 | 11.88% |
| 2015 | 24.32 | -64.92% |
| 2014 | 69.33 | 145.16% |
| 2013 | 28.28 | 75.92% |
| 2012 | 16.07 | 12.53% |
| 2011 | 14.28 | -14.55% |
| 2010 | 16.72 | -7.52% |
| 2009 | 18.08 | 27.26% |
| 2008 | 14.20 | -52.79% |
| 2007 | 30.09 | 4.28% |
| 2006 | 28.85 | 8.62% |
| 2005 | 26.56 | -36.09% |
| 2004 | 41.57 | 6.61% |
| 2003 | 38.99 | -3.57% |
| 2002 | 40.43 | -4.42% |
| 2001 | 42.30 | -5.53% |
| 2000 | 44.78 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 33.11 | 14.39% |
US
|
|
| 21.39 | -26.11% |
IE
|
|
| 17.34 | -40.10% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 71.65% |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.